Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

1.55
+0.05003.33%
Post-market: 1.560.0056+0.36%19:56 EST
Volume:87.65K
Turnover:133.94K
Market Cap:17.70M
PE:-0.81
High:1.58
Open:1.50
Low:1.47
Close:1.50
52wk High:7.95
52wk Low:1.42
Shares:11.42M
Float Shares:9.35M
Volume Ratio:0.63
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9054
EPS(LYR):-2.2184
ROE:-335.45%
ROA:-49.76%
PB:6.99
PE(LYR):-0.70

Loading ...

Vivos Therapeutics Appoints Gregg Johnson to Board

TIPRANKS
·
12 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares

Reuters
·
Yesterday

Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies

Reuters
·
Feb 05

Vivos Therapeutics and Soundhealth Announce Collaboration to Expand Access to Soundhealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

THOMSON REUTERS
·
Feb 05

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

GlobeNewswire
·
Jan 21

Vivos Therapeutics Completes Warrant Inducement Financing Transaction

TIPRANKS
·
Jan 21

Vivos Therapeutics Raises $4.6 Million Through Warrant Exercise at Reduced Price

Reuters
·
Jan 21

Vivos Therapeutics Secures Convertible Bridge Financing Facility

TIPRANKS
·
Jan 17

Vivos Therapeutics Secures $5.5 Million in Unregistered Private Placement

Reuters
·
Jan 17

Vivos Therapeutics Raises $4.64 Million Through Warrant Exercise

Reuters
·
Jan 16

Press Release: Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dow Jones
·
Jan 16

Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS)

TIPRANKS
·
Jan 09

Vivos Therapeutics Opens New Sleep Center in Auburn Hills, Michigan

Reuters
·
Dec 16, 2025

Vivos Therapeutics Executives Join Water Tower Research Online Fireside Chat

Reuters
·
Dec 16, 2025

Vivos Therapeutics Secures $2.1 Million Unsecured Loan from Avondale Capital

Reuters
·
Dec 06, 2025

Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 03, 2025

Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges

TIPRANKS
·
Nov 22, 2025

Vivos Therapeutics Reports Revenue Growth Amid Strategic Shift

TIPRANKS
·
Nov 20, 2025

Vivos Therapeutics Reports 78% Sequential Revenue Growth in Third Quarter 2025

Reuters
·
Nov 20, 2025

Vivos Therapeutics Q3 revenue rises, helped by SCN acquisition

Reuters
·
Nov 20, 2025